SCHEMBL14601732

SCHEMBL14601732

O=S(=O)(Cc1c(Cl)cccc1Cl)c1cc(C(F)(F)F)cc(C(F)(F)F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.47
RECQL P46063 1/20 0.45
P2RX1 P51575 1/20 0.42
P2RX4 Q99571 1/20 0.42
P2RX7 Q99572 1/20 0.42
TMPRSS4 Q9NRS4 1/20 0.42
AKR1B1 P15121 2/20 0.41
POLB P06746 2/20 0.41
MCL1 Q07820 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
MMP8 P22894 1/20 0.40
MMP13 P45452 1/20 0.40
MAPT P10636 3/20 0.39
LMNA P02545 2/20 0.39
GAA P10253 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14458062 0.76 DDR1 (0.44) KMT2AP2RX1POLBMAPTLMNA
SCHEMBL8693173 0.74 AKR1B1 (0.49) KMT2AAKR1B1POLBMAPTGAA
SCHEMBL1148973 0.72 CES2 (0.43) KMT2ARECQLPOLBCA1CA2
SCHEMBL18442740 0.71 KMT2A (0.46) KMT2AP2RX1POLBMAPTLMNA
SCHEMBL7638364 0.70 AKR1B1 (0.45) KMT2ARECQLAKR1B1POLBMAPT
SCHEMBL14601731 0.70 ALDH1A1 (0.48) KMT2ARECQLAKR1B1POLBMAPT
SCHEMBL5871962 0.70 AKR1B1 (0.45) KMT2AAKR1B1MAPTKDM4E
SCHEMBL13063654 0.70 CES2 (0.45) CA1CA2MMP1MMP2MMP9
SCHEMBL18443094 0.70 POLB (0.40) KMT2AP2RX1POLBMAPTLMNA
SCHEMBL20752339 0.68 POLB (0.59) KMT2ARECQLAKR1B1POLBCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070021509-A1 Phosphate transport inhibitors JOZEFIAK THOMAS H 2007-01-25 US disclosed
US-20070021509-A1 Phosphate transport inhibitors JOZEFIAK THOMAS H 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021509-A1 Phosphate transport inhibitors SLC34A2, SLC34A1, SLC20A1 KMT2A 4634/4885RECQL 1078/4885P2RX1 244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.